Squar Milner Financial Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Squar Milner Financial Services’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,640	Closed	-$109K	–	390
2020 Q1	$109K	Hold	5,640	–	–	0.07%	240
2019 Q4	$131K	Buy	+5,640	New	+$123K	0.07%	272
2019 Q3	–	Sell	-5,640	Closed	-$119K	–	394
2019 Q2	$119K	Hold	5,640	–	–	0.08%	247
2019 Q1	$120K	Hold	5,640	–	–	0.09%	237
2018 Q4	$108K	Hold	5,640	–	–	0.1%	214
2018 Q3	$132K	Buy	5,640 +5,050	+856%	+$117K	0.12%	208
2018 Q2	$13K	Buy	+590	New	+$12.6K	0.01%	538

Other funds holding FTXH

JAWM

J. Arnold Wealth Management Youngstown, Ohio $294M AUM 33.6% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return

Squar Milner Financial Services's FTXH Position: Q2 2020 in Review

Squar Milner Financial Services sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2020, closing a stake of 5,640 shares — an estimated $109K sold.

Squar Milner Financial Services first reported a position in FTXH in Q2 2018 and held it in 7 quarters. The position peaked at $132K in Q3 2018. 13 funds tracked by Wall St. Rank hold FTXH as of Q2 2020.

Squar Milner Financial Services reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2020 after selling out during the quarter.
Squar Milner Financial Services sold 5,640 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2020, an estimated $109K.
Squar Milner Financial Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2018 and held it in 7 quarters.
Squar Milner Financial Services's First Trust Nasdaq Pharmaceuticals ETF position peaked at $132K in Q3 2018.
13 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.